Advanced NanoTherapies Revenue and Competitors
Estimated Revenue & Valuation
- Advanced NanoTherapies's estimated annual revenue is currently $2.1M per year.
- Advanced NanoTherapies's estimated revenue per employee is $133,344
- Advanced NanoTherapies's total funding is $5.3M.
Employee Data
- Advanced NanoTherapies has 16 Employees.
- Advanced NanoTherapies grew their employee count by 0% last year.
Advanced NanoTherapies's People
Name | Title | Email/Phone |
---|---|---|
1 | President, CEO, and co-founder | Reveal Email/Phone |
2 | President, CEO and Co-Founder | Reveal Email/Phone |
3 | Director - Engineering | Reveal Email/Phone |
4 | Sr. Director R&D | Reveal Email/Phone |
5 | Quality Manager | Reveal Email/Phone |
6 | Senior Manager, Product Development | Reveal Email/Phone |
7 | Medical Writer | Reveal Email/Phone |
8 | Product Development Engineer | Reveal Email/Phone |
9 | Research Scientist | Reveal Email/Phone |
Advanced NanoTherapies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 79 | 20% | N/A | N/A |
#2 | $8.5M | 31 | 11% | N/A | N/A |
#3 | $4.5M | 13 | -13% | N/A | N/A |
#4 | $8M | 25 | -4% | N/A | N/A |
#5 | $5.3M | 16 | -6% | N/A | N/A |
#6 | $54.2M | 163 | -8% | N/A | N/A |
#7 | $12M | 55 | -17% | N/A | N/A |
#8 | $10M | 30 | -9% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 43 | -7% | N/A | N/A |
What Is Advanced NanoTherapies?
AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention. We are developing novel Sirolimus-based medical devices to treat atherosclerosis and blockage for Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD).
keywords:N/A$5.3M
Total Funding
16
Number of Employees
$2.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.4M | 16 | N/A | N/A |
#2 | N/A | 16 | 0% | N/A |
#3 | $1.5M | 17 | 13% | N/A |
#4 | $28.6M | 17 | -79% | N/A |
#5 | $1.6M | 17 | 0% | N/A |